|
End-of-day quote
Buenos Aires S.E.
2026-09-29
|
5-day change | 1st Jan Change | ||
| 58,675.00 ARS | -1.22% |
|
+3.99% | +10.55% |
| 08:24am | Merck's experimental skin disease drug succeeds in mid-stage study | RE |
| 08:20am | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.24% | +2.15% | +1.65% | -1.97% | +9.41% | +54.10% | +118.43% | +408.88% | +1,364.94% | 1,056B | |
| -0.20% | -0.81% | +0.43% | +5.12% | +29.01% | +43.99% | +72.08% | +65.31% | +126.01% | 645B | |
| +0.15% | -0.49% | +2.87% | +4.82% | +15.44% | +13.92% | +77.93% | +144.54% | +318.23% | 465B | |
| -1.82% | -1.15% | -0.94% | +13.91% | +39.06% | +74.40% | +42.73% | +94.87% | +134.53% | 368B | |
| -0.06% | -3.88% | -1.05% | +4.90% | +6.37% | +34.32% | +40.74% | +2.09% | +44.85% | 335B | |
| -0.79% | +2.01% | -2.68% | -5.23% | +9.45% | +19.82% | +28.48% | +56.14% | +57.02% | 275B | |
| -1.19% | -1.21% | +2.66% | -12.91% | -10.95% | +9.82% | +12.15% | +37.08% | +145.40% | 255B | |
| -0.22% | +3.98% | -1.77% | +16.61% | +29.01% | +49.63% | +58.56% | +98.57% | +153.14% | 229B | |
| -0.85% | -0.89% | +2.51% | +18.74% | +22.23% | +35.15% | +102.46% | +114.77% | +89.61% | 188B | |
| +0.62% | +0.38% | -13.41% | -19.52% | -22.15% | -26.53% | -60.24% | -18.51% | +83.88% | 169B | |
| +0.23% | +2.08% | +1.07% | +19.46% | +15.52% | +12.89% | -15.25% | -33.12% | -15.07% | 164B | |
| -0.25% | +2.22% | -3.07% | +6.25% | +16.42% | +34.76% | +51.74% | +190.97% | +505.19% | 134B | |
| +0.17% | +2.86% | -5.85% | +9.16% | +16.61% | +39.47% | +8.73% | +6.30% | +16.65% | 128B | |
| -0.15% | -2.03% | -2.56% | +14.17% | +5.17% | +11.67% | +97.22% | +332.67% | +417.34% | 101B | |
| -1.29% | -2.86% | -2.11% | -7.52% | +0.41% | +16.35% | +23.45% | +4.42% | -10.80% | 98.21B | |
| +1.64% | -0.64% | -5.43% | -3.25% | -12.19% | -7.52% | -28.66% | -12.57% | +7.39% | 97.03B | |
| -7.55% | +3.77% | +34.66% | +169.86% | +540.83% | +631.63% | +82.93% | -50.90% | - | 81.23B | |
| +0.35% | -5.76% | -5.44% | +21.18% | -2.11% | +34.38% | -7.63% | +24.86% | +87.95% | 74.94B | |
| +0.51% | +3.87% | -0.65% | -5.96% | +12.64% | +26.18% | -10.61% | -26.41% | +43.99% | 67.69B | |
| Average | -0.52% | +0.19% | +0.05% | +13.04% | +37.90% | +58.34% | +36.59% | +75.79% | +198.35% | 259.47B | |
| Weighted average by Cap. | -0.37% | +0.28% | +0.16% | +6.10% | +22.33% | +45.00% | +59.00% | +140.41% | +406.77% |
- Stock Market
- Stocks
- NOVN Stock
- NVS Stock
- Sector Novartis AG
Select your edition
All financial news and data tailored to specific country editions
